Effect of caffeine coadministration and of nitric oxide synthesis inhibition on the antinociceptive action of ketorolac

European Journal of Pharmacology

Volumn 308, Issue 3, 1996, Pages 275-277

  López Muñoz, Francisco J ^a   Castañeda Hernández, Gilberto ^a   Flores Murrieta, Francisco J ^a   Granados Soto, Vinicio ^a  

^a Seccion de Terapeutica Experimental   (Mexico)

Author keywords

Antinociception; Caffeine; Ketorolac; N(G) Nitro L arginine methyl ester (L NAME); Nitric oxide (NO); Potentiation

Indexed keywords

ARGININE; CAFFEINE; CYCLIC GMP; KETOROLAC; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; INTRAARTICULAR DRUG ADMINISTRATION; JOINT FUNCTION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0030601248     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00320-2     Document Type: Article

References (12)

1. Canadian Council on Animal Care, 1989, Ethics of Animal Investigation, Canadian Council on Animal Care, Ottawa, Ont.
2. Castañeda-Hernández, G., M.S. Castillo-Méndez, F.J. Lõpez-Muñoz, V. Granados-Soto and F.J. Flores-Murrieta, 1994, Potentiation by caffeine of the analgesic effect of aspirin in the pain-induced functional impairment model in the rat, Can. J. Physiol. Pharmacol. 72, 1127.
3. Ferreira, S.H., 1972, Prostaglandins, aspirin like drugs and analgesia, Nature 240, 200.
4. Granados-Soto, V., F.J. López-Muñoz, G. Castañeda-Hemández, L.A. Salazar, J.E. Villarreal and F.J. Flores-Murrieta, 1993, Characterization of the analgesic effects of paracetamol and caffeine combinations in the pain-induced functional impairment model in the rat, J. Pharm. Pharmacol. 45, 627.
5. Granados-Soto, V., F.J. Flores-Murrieta, G. Castañeda-Hernández and F.J. López-Muñoz, 1995, Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolac in the rat, Eur. J. Pharmacol. 277, 281.
6. Hatano, Y., K. Mizumoto, T. Yoshiyama, M. Yamamoto and H Iranami, 1995, Endothelium-dependent and -independent vasodilation of isolated rat aorta induced by caffeine, Am. J. Physiol. 269, H1679.
7. López-Muñoz, F.J., L.A. Salazar, G. Castañeda-Hernández and J.E. Villarreal, 1993, A new model to assess analgesic activity: pain-induced functional impairment in the rat (PIFIR), Drug Dev. Res. 28, 169.
8. Rees, D.D., R.M.S. Palmer, R. Schulz, H.F. Hodson and S. Moncada, 1990, Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo, Br. J. Pharmacol. 101, 746.
9. Sawynok, J. and T.L. Yaksh, 1993, Caffeine as an anagesic adjuvant: a review of its pharmacology and mechanisms of action, Pharmacol. Rev. 45, 43.
10. Tjölsen, A., O.G. Berge, S. Hunskaar, J.H. Rosland and K. Hole, 1992, The formalin test: an evaluation of the method, Pain 51, 5.
11. Tonussi, C.R. and S.H. Ferreira, 1994, Mechanism of diclofenac antinociception: direct blockade of inflammatory sensitization, Eur. J. Pharmacol. 251, 173.
12. Zimmermann, M., 1983, Ethical guidelines for investigation on experimental pain in conscious animals, Pain 16, 109.